Ariad Pharmaceuticals Inc fka ARIA

[jochenVt]

I would still like to see them partnering the shelved molecule.
Whatever this molecule was everybody considers it dead for now and let's be realistic, they will not take it off the shelf for at least 2-3 years.
Now if they could find a partner to pay for development (worst, worst case: give somebody 50% just for paying for development and no additional milestones), they
- grow the discovery team and develop the discovery platform
- get paid for part of the facilities, overhead, etc reducing their running costs (turn them into briskly walking costs if you will)
- mitigate future risks as there is now one more drug in the pipeline